Clinical risk factors for proliferative vitreoretinopathy

M. Cowley, B. P. Conway, P. A. Campochiaro, D. Kaiser and H. Gaskin
Department of Ophthalmology, University of Virginia Health Sciences Center, Charlottesville 22908.

We reviewed the records of all patients with rhegmatogenous retinal detachments examined and treated by a single surgeon (B.P.C.) at the University of Virginia, Charlottesville, between 1978 and 1984. Of the 607 eyes that satisfied the selection criteria, a preliminary chart review of outcomes found that 65 (10.7%) had proliferative vitreoretinopathy and 34 had macular puckers. From the remaining 508 eyes, 325 controls were randomly selected to match each case from within a time window. Thirty-six (55.4%) of the 65 patients with proliferative vitreoretinopathy had had unequivocal reattachment after a single procedure before the onset of proliferative vitreoretinopathy, and the only clearly identified technical difficulty that was significantly more common in the patients with proliferative vitreoretinopathy was the inability to identify a retinal break. Several other features of the rhegmatogenous retinal detachments that correlated with the development of postoperative proliferative vitreoretinopathy were identified, and stepwise discriminant analysis was used to ascertain which of these were more important. The strongest predictor was use of vitrectomy in management of the detachment. Following this in order of importance were the presence of preoperative proliferative vitreoretinopathy, preoperative choroidal detachment, and the amount of cryopexy required. Vitrectomy remained a strong predictor even when considered after adjustment for all other characteristics. These data suggest that proliferative vitreoretinopathy is not simply an iatrogenic disease, but it is more likely to occur in association with certain detachment features that either by themselves or through their management require prolongation of the retinal wound healing process.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraocular Nanoparticle Drug Delivery: A Pilot Study Using an Aerosol during Pars Plana Vitrectomy
Zhang et al.
IOVS 2007;48:5243-5249.
ABSTRACT | FULL TEXT  

The Role of Gremlin, a BMP Antagonist, and Epithelial-to-Mesenchymal Transition in Proliferative Vitreoretinopathy
Lee et al.
IOVS 2007;48:4291-4299.
ABSTRACT | FULL TEXT  

The Insulin-Like Growth Factor System Modulates Retinal Pigment Epithelial Cell Tractional Force Generation
Mukherjee and Guidry
IOVS 2007;48:1892-1899.
ABSTRACT | FULL TEXT  

Buckle, no cryo: scleral buckle with no cryotherapy for retinal detachment secondary to commotio retinae.
Majid et al.
Br. J. Ophthalmol. 2006;90:1550-1551.
FULL TEXT  

Tailored vitrectomy and laser photocoagulation without scleral buckling for all primary rhegmatogenous retinal detachments
Johansson et al.
Br. J. Ophthalmol. 2006;90:1286-1291.
ABSTRACT | FULL TEXT  

An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy
Cardillo et al.
Br. J. Ophthalmol. 2004;88:1201-1205.
ABSTRACT | FULL TEXT  

The Kinase Inhibitor PKC412 Suppresses Epiretinal Membrane Formation and Retinal Detachment in Mice with Proliferative Retinopathies
Saishin et al.
IOVS 2003;44:3656-3662.
ABSTRACT | FULL TEXT  

Photoreceptor-Specific Expression of Platelet-Derived Growth Factor-B Results in Traction Retinal Detachment
Seo et al.
Am. J. Pathol. 2000;157:995-1005.
ABSTRACT | FULL TEXT  

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study
Kon et al.
Br. J. Ophthalmol. 2000;84:506-511.
ABSTRACT | FULL TEXT  

Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy
Limb and Chignell
Br. J. Ophthalmol. 1999;83:953-956.
ABSTRACT | FULL TEXT  

Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders
Cassidy et al.
Br. J. Ophthalmol. 1998;82:181-185.
ABSTRACT | FULL TEXT  

Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes
Chen et al.
Br. J. Ophthalmol. 1997;81:919-926.
ABSTRACT | FULL TEXT  

Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells
Campochiaro et al.
J. Cell Sci. 1994;107:2459-2469.
ABSTRACT